Chamber and committees

Questions and answers

Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.

Written questions must be answered within 10 working days (20 working days during recess)
Other questions such as Topical, Portfolio, General and First Minister's Question Times are taken in the Chamber

Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.

Find out more about parliamentary questions

Filter your results Hide all filters

Displaying 48497 questions Show Answers

Order by |

Question reference: S6O-00824

Asked by: Sarah Boyack, MSP for Lothian, Scottish Labour
Date lodged: Wednesday, 02 March 2022
Current Status: Taken in the Chamber on 9 March 2022

To ask the Scottish Government whether it will meet with the Life after Essure UK and Ireland support group to discuss its concerns about a lack of awareness and understanding of the reported damaging physical and mental health impacts of Essure sterilisation devices.

Question reference: S6O-00841

Asked by: Jamie Halcro Johnston, MSP for Highlands and Islands, Scottish Conservative and Unionist Party
Date lodged: Wednesday, 02 March 2022
Current Status: Taken in the Chamber on 10 March 2022

To ask the Scottish Government whether it will ensure that any proposed legislation in the Constitution, External Affairs and Culture portfolio is brought forward in a fair and transparent manner.

Question reference: S6O-00832

Asked by: Sue Webber, MSP for Lothian, Scottish Conservative and Unionist Party
Date lodged: Wednesday, 02 March 2022
Current Status: Taken in the Chamber on 9 March 2022

To ask the Scottish Government what its response is to the comments by the president of COSLA, who said that local authorities are at breaking point.

Question reference: S6O-00830

Asked by: Emma Harper, MSP for South Scotland, Scottish National Party
Date lodged: Wednesday, 02 March 2022
Current Status: Taken in the Chamber on 9 March 2022

To ask the Scottish Government how its housing strategy will support local authorities to take action in relation to vacant, derelict and abandoned buildings.

Question reference: S6O-00840

Asked by: Donald Cameron, MSP for Highlands and Islands, Scottish Conservative and Unionist Party
Date lodged: Wednesday, 02 March 2022
Current Status: Taken in the Chamber on 10 March 2022

To ask the Scottish Government whether it will provide an update on any legal advice it has sought for its proposed Independence Referendum Bill.

Question reference: S6O-00827

Asked by: Joe FitzPatrick, MSP for Dundee City West, Scottish National Party
Date lodged: Wednesday, 02 March 2022
Current Status: Taken in the Chamber on 9 March 2022

To ask the Scottish Government what support it is providing to people at risk of alcohol harm in the most disadvantaged communities.

Question reference: S6O-00825

Asked by: Jenni Minto, MSP for Argyll and Bute, Scottish National Party
Date lodged: Wednesday, 02 March 2022
Current Status: Taken in the Chamber on 9 March 2022

To ask the Scottish Government how decisions are made regarding the location of dialysis units.

Question reference: S6O-00831

Asked by: Emma Roddick, MSP for Highlands and Islands, Scottish National Party
Date lodged: Wednesday, 02 March 2022
Current Status: Taken in the Chamber on 9 March 2022

To ask the Scottish Government whether it will provide an update on the allocation of Discretionary Housing Payments in Scotland.

Question reference: S6W-06325

Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
Date lodged: Tuesday, 08 February 2022
Current Status: Answered by Michael Matheson on 2 March 2022

To ask the Scottish Government, further to the answer to question S6W-05609 by Michael Matheson on 17 January 2022, whether it will provide the information requested regarding what consideration Scottish Water gave to the minimum income expectation set by the Water Industry Commission for Scotland within the 2021-27 final determination of charges when setting charge levels for 2022-23; how Scottish Water assessed the economic circumstances of the customers referred to; what view Scottish Water’s customer advisory body gave on the charges proposed, and whether it was consulted prior to Scottish Water making its charging decisions for the 2022-23 financial year.

The Water Industry Commission for Scotland has responsibility for setting charge caps and otherwise sets out expectations or forecasts including for income as a guide to Scottish Water and stakeholders. Consideration of the economic circumstances of customers encompassed both GDP growth and the GDP level relative to pre-pandemic, wage growth relative to inflation and unemployment levels. Scottish Water’s Independent Customer Group was consulted prior to Scottish Water making its charging decisions for the 2022-23 financial year and its clear preference was to see increases held to around 4%.

Whilst there is no formal requirement to consult the Scottish Government, Ministers were made aware of the outcome of the independent process, including the rationale underpinning the decision by Scottish Water's Board on the scheme of charges for 2022-23.

Question reference: S6W-06808

Asked by: Beatrice Wishart, MSP for Shetland Islands, Scottish Liberal Democrats
Date lodged: Thursday, 24 February 2022
Current Status: Answered by Maree Todd on 2 March 2022

To ask the Scottish Government how the site-specific brain tumour research funding that is provided through the Chief Scientist Office is allocated between the National Cancer Research Institute (NCRI) Common Scientific Outline categories of (a) biology, (b) aetiology, (c) prevention, (d) early detection, diagnosis and prognosis, (e) treatment and (f) cancer control, survivorship and outcomes research.

A search of the National Cancer Research Institute (NCRI) Cancer Research Database (CaRD) carried out by NCRI at the request of the Chief Scientist Office (CSO) showed the following allocation for CSO funded site-specific brain tumour research by Common Scientific Outline category

Category 1. Biology - total 4.1% /£22,275

Sub-category 1.5: Resources and Infrastructure - £22,275

Category 2. Aetiology

Category 3. Prevention

Category 4. Early Detection, Diagnosis and Prognosis - total 59.9% /£325,022

Sub-category 4.1: Technology Development and/or Marker Discovery - £67,767

Sub-category 4.2: Technology and/or Marker Evaluation - £134,305

Sub-category 4.4: Resources and Infrastructure Related to Detection, Diagnosis, or Prognosis - £122,950

Category 5. Treatment - total 35.6% / £192,875

Sub-category 5.3: Systemic Therapies - Discovery and Development - £13,928

Sub-category 5.4: Systemic Therapies - Clinical Applications - £48,685

Sub-category 5.7: Resources and Infrastructure Related to Treatment and the Prevention of Recurrence £130,262

Category 6. Cancer Control, Survivorship, and Outcomes Research - total 0.4% / £2,195

Sub-category 6.2: Surveillance - £2,195

In the June 2021 round of the CSO Translational Clinical Studies Committee, the following research project was funded:

Developing representative models of the blood-tumour barrier to enhance drug development for Glioblastoma

Lead Investigator: Prof. Anthony Chalmers / Univeristy of Glasgow / £296,864 TCS2105.pdf (scot.nhs.uk)

This project will be categorised at the next update of the NCRI CaRD (scheduled Summer 2022)